Literature DB >> 18852950

Levels of carcinoembryonic antigen and CA 19-9 in the sera and peritoneal washing of patients undergoing surgical treatment for gastric carcinoma.

René Crepaldi-Filho1, Rogério Tadeu Palma, Marcelo Franchini Giusti, Marina de Assis Galvão Bueno, Paulo Sérgio Lucas da Silva, Jaques Waisberg.   

Abstract

BACKGROUND: Early peritoneal recurrence of gastric carcinoma following curative resection remains a great challenge in the treatment and prevention of this disease. AIM: To analyze the relationship between levels of tumor markers, carcinoembryonic antigen (CEA) and CA 19-9 in the sera and peritoneal washing, and anatomopathological aspects of the gastric carcinoma.
METHODS: Of the 46 patients in the study, 29 (63.0%) were males and 17 (37.0%) females. Mean age was 63.6 +/- 11.7 years (31 to 91 years). Peripheral venous blood samples were collected from the upper limb vein from both patient groups after anesthetic induction, in order to determine serum levels of CEA and CA 19-9. After the end of the procedure, 50 mL of physiologic solution was introduced into the bottom of the Douglas sack and a portion aspirated to determine CEA and CA 19-9 levels in the peritoneal washing. Levels of CEA and CA 19-9 in the sera and peritoneal washing were compared to the following variables: lesion diameter < or = 4 cm or > 4 cm, lymph node involvement, angiolymphatic invasion, depth of invasion into gastric wall, and initial or late stage.
RESULTS: Sera CEA levels were significantly higher in patients with lesions >5 cm. CEA levels in the sera and peritoneal washing were significantly greater in patients with signet ring cell gastric carcinoma. In addition, levels of CEA in peripheral blood and peritoneal washing showed significant association with the degree of carcinoma penetration into the gastric wall, while sera CEA was significantly higher in patients at more advanced stages. There was no significant difference between sera and peritoneal CEA values regarding grade of differentiation. Patients with gastric lesions measuring > 5 cm and more differentiated lesions had significantly higher sera CA 19-9 values. In patients with lymph nodes invasion by gastric carcinoma, CA 19-9 levels in peritoneal washing were significantly higher than in peripheral blood. Levels of CA 19-9 in peritoneal washing were significantly greater at advanced stages than the initial stage of the gastric carcinoma.
CONCLUSIONS: Elevated levels of CA 19-9 in peritoneal washing were significantly associated with more advance stages of gastric carcinoma and was more reliable predictive factor for staging than sera CA 19-9 levels. CEA levels in the sera more accurately reflected neoplasia stage than levels in peritoneal washing.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18852950     DOI: 10.1590/s0004-28032008000300010

Source DB:  PubMed          Journal:  Arq Gastroenterol        ISSN: 0004-2803


  4 in total

1.  Upregulation of plasma C9 protein in gastric cancer patients.

Authors:  Poh-Kuan Chong; Huiyin Lee; Marie Chiew Shia Loh; Lee-Yee Choong; Qingsong Lin; Jimmy Bok Yan So; Khong Hee Lim; Ross Andrew Soo; Wei Peng Yong; Siew Pang Chan; Duane T Smoot; Hassan Ashktorab; Khay Guan Yeoh; Yoon Pin Lim
Journal:  Proteomics       Date:  2010-09       Impact factor: 3.984

2.  Use of serum and peritoneal CEA and CA19-9 in prediction of peritoneal dissemination and survival of gastric adenocarcinoma patients: are they prognostic factors?

Authors:  M Hasbahceci; F U Malya; E Kunduz; M Guzel; N Unver; A Akcakaya
Journal:  Ann R Coll Surg Engl       Date:  2018-03-15       Impact factor: 1.891

3.  Control values of ovarian cancer tumor markers and standardisation of a protocol for sampling peritoneal fluid and performing washing during laparoscopy.

Authors:  Katarina Galic Jerman; Borut Kobal; Marina Jakimovska; Ivan Verdenik; Katarina Cerne
Journal:  World J Surg Oncol       Date:  2014-09-04       Impact factor: 2.754

4.  Diagnostic Utility of Combined CEA, CA15-3 and CA125 Biomarkers and Cytomorphology in Suspicious and Malignant Serosal Fluid.

Authors:  Zahra Rahemi; Abdolreza Javadi; Behrang Kazeminejad; Abdolali Ebrahimi; Houman Vosough; Afsoon Taghavi; Shahriar Dabiri
Journal:  Iran J Pathol       Date:  2021-05-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.